Managing Extractables & Leachables: Early Planning with Your CDMO

Published on Cell & Gene

Extractables and leachables (E&L) testing is a critical regulatory expectation in cell and gene therapy manufacturing. This article explains why engaging your CDMO early on E&L strategies can prevent delays, ensure regulatory alignment, and support product safety from the start.

Read the full article on Cell & Gene:

👉 Extractables and Leachables: Setting Up Early for Success with Your CDMO

Images used are for illustrative purposes only and do not depict actual persons, products, or facilities. For full details, please refer to the original article via the provided link.